{
    "2020-01-24": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Johnson & Johnson Stock at Cusp of Historic Breakout",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "historic breakout"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Top Stock Research Reports for Intel, Boeing & Blackstone",
                "features": {
                    "keywords": [
                        "Intel",
                        "Boeing",
                        "Blackstone",
                        "research reports"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "aerospace",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-05",
                "original_text": "Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU",
                "features": {
                    "keywords": [
                        "pharma stock",
                        "J&J",
                        "Roche",
                        "Novartis",
                        "Q4",
                        "drug approval"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-25",
                "original_text": "J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stelara",
                        "EU nod",
                        "plaque psoriasis",
                        "children"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}